SCHEMBL20916362

SCHEMBL20916362

CN(C)/C=N/S(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1-c1cn[nH]c1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 4/20 0.63
▸ ROCK1 Q13464 4/20 0.63
▸ KCNJ6 P48051 2/20 0.50
▸ KCNJ5 P48544 2/20 0.50
▸ KCNJ3 P48549 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ CLK2 P49760 1/20 0.45
▸ PRKX P51817 1/20 0.45
▸ CAMK2D Q13557 1/20 0.45
▸ PKN2 Q16513 1/20 0.45
▸ CLK4 Q9HAZ1 1/20 0.45
▸ STK17A Q9UEE5 1/20 0.45
▸ P2RX4 Q99571 13/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19551941 1.00 ROCK2 (0.63) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL19552825 0.87 KCNJ6 (0.49) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL19552826 0.87 KCNJ6 (0.49) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL20916441 0.87 KCNJ6 (0.52) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL19551586 0.87 KCNJ5 (0.52) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL20916408 0.87 KCNJ5 (0.52) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL19552795 0.87 KCNJ6 (0.54) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL20916442 0.87 KCNJ6 (0.52) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL29718795 0.87 KCNJ6 (0.52) ROCK2ROCK1KCNJ6KCNJ5KCNJ3
SCHEMBL19552794 0.87 KCNJ6 (0.54) ROCK2ROCK1KCNJ6KCNJ5KCNJ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458443-B1 AROMATIC SULFONAMIDE DERIVATIVES Bayer Pharma AG (DE) 2020-08-19 — — EP claimed
US-20190119210-A1 AROMATIC SULFONAMIDE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-04-25 — — US claimed
US-11524938-B2 Aromatic sulfonamide derivatives BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-12-13 — — US disclosed
US-20220324807-A1 AROMATIC SULFONAMIDE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-10-13 — — US disclosed
EP-3763704-A1 AROMATIC SULFONAMIDE DERIVATIVES Bayer Pharma Aktiengesellschaft (DE) 2021-01-13 — — EP disclosed
US-10844016-B2 Aromatic sulfonamide derivatives BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-11-24 — — US disclosed
EP-3458443-B1 AROMATIC SULFONAMIDE DERIVATIVES Bayer Pharma AG (DE) 2020-08-19 — — EP disclosed
US-20190119210-A1 AROMATIC SULFONAMIDE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119210-A1 AROMATIC SULFONAMIDE DERIVATIVES ARSA, SULT2A1, TPST2 ROCK2 4741/4885ROCK1 4787/4885KCNJ6 2337/4885
US-20220324807-A1 AROMATIC SULFONAMIDE DERIVATIVES ARSA, SULT2A1, TPST2 ROCK2 4741/4885ROCK1 4787/4885KCNJ6 2337/4885
US-11524938-B2 Aromatic sulfonamide derivatives ARSA, SULT2A1, TPST2 ROCK2 4741/4885ROCK1 4787/4885KCNJ6 2337/4885
US-10844016-B2 Aromatic sulfonamide derivatives ARSA, SULT2A1, TPST2 ROCK2 4741/4885ROCK1 4787/4885KCNJ6 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback